Form 4 Tracker
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA

72 insider filings · Latest: Sep 19, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 4, 2026Mar 4 10:22 PMDaniell Richard
Proposed Sale
91,345$32.66$3.0M—

View →

Mar 3, 2026Mar 3 10:46 PMSavage Brian
Proposed Sale
1,274$32.36$41.2K—

View →

Mar 3, 2026Mar 3 10:34 PMFrancis Richard D
Proposed Sale
442,935$32.36$14.3M—

View →

Mar 3, 2026Mar 3 10:25 PMHughes Eric A
Proposed Sale
80,762$32.36$2.6M—

View →

Mar 3, 2026Mar 3 10:13 PMDaniell Richard
Proposed Sale
128,985$32.36$4.2M—

View →

Feb 26, 2026Mar 2 9:01 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Sale
345,810$33.64$11.6M57,478(D)

View →

Feb 26, 2026Feb 26 9:11 PMKalif Eliyahu Sharon
Proposed Sale
345,810$33.64$11.6M—

View →

Feb 15, 2026Feb 18 9:01 PMRichard D FrancisPresident and CEO
Sale
447,778$34.22$15.3M605,771(D)

View →

Feb 17, 2026Feb 18 11:28 AMFrancis Richard D
Proposed Sale
447,778$34.22$15.3M—

View →

Feb 17, 2026Feb 18 11:12 AMFrancis Richard D
Proposed Sale
447,778$1.00$447.8K—

View →

Dec 12, 2025Dec 12 9:17 PMBridger Management, LLC (1)
Proposed Sale
150,000$30.18$4.5M—

View →

Dec 9, 2025Dec 9 9:03 PMSabag Mark
Proposed Sale
216,892$28.73$6.2M—

View →

Dec 9, 2025Dec 9 9:00 PMDaniell Richard
Proposed Sale
115,468$28.68$3.3M—

View →

Nov 26, 2025Nov 26 9:02 PMBridger Management, LLC (1)
Proposed Sale
50,000$24.99$1.2M—

View →

Nov 20, 2025Nov 20 9:19 PMFox Christine
Proposed Sale
28,229$24.78$699.5K—

View →

Nov 14, 2025Nov 14 8:59 PMFox Christine
Proposed Sale
30,000$25.11$753.3K—

View →

Nov 6, 2025Nov 7 12:46 AMBridger Management, LLC (1)
Proposed Sale
200,000$24.60$4.9M—

View →

Sep 12, 2025Sep 12 8:05 PMBridger Management, LLC (1)
Proposed Sale
95,000$19.89$1.9M—

View →

Aug 1, 2025Aug 1 8:04 PMJover Placid
Proposed Sale
6,053$15.16$91.7K—

View →

Aug 1, 2025Aug 1 8:01 PMHughes Eric A
Proposed Sale
52,742$15.16$799.4K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 28, 2026Jun 1 8:08 PMRosemary A CraneDirector
Grant/Award
7,242—7,242(D)

View →

May 28, 2026Jun 1 8:06 PMChen LichtensteinDirector
Grant/Award
7,242—7,242(D)

View →

May 28, 2026Jun 1 8:03 PMBARER SOL JDirector
Grant/Award
10,863—10,863(D)

View →

May 28, 2026Jun 1 8:02 PMRoberto MignoneDirector
Grant/Award
7,242—7,242(D)

View →

May 14, 2026May 18 8:02 PMEvan LippmanEVP, Business Development
Option Exercise
85,849—74,008(D)

View →

Mar 5, 2026Mar 9 8:23 PMMark SabagSee "Remarks"
Option Exercise
15,723—47,170(D)

View →

Mar 5, 2026Mar 9 8:22 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Option Exercise
19,916—59,748(D)

View →

Mar 5, 2026Mar 9 8:19 PMAmir WeissChief Accounting Officer
Option Exercise
3,537—10,613(D)

View →

Mar 5, 2026Mar 9 8:18 PMRichard D FrancisPresident and CEO
Option Exercise
42,452—127,359(D)

View →

Mar 5, 2026Mar 9 8:16 PMChristine FoxEVP, U.S. Commercial
Option Exercise
17,819—53,459(D)

View →

Mar 5, 2026Mar 9 8:14 PMEric A HughesSee "Remarks"
Option Exercise
19,654—58,962(D)

View →

Mar 5, 2026Mar 9 8:12 PMRichard DaniellEVP, Europe Commercial
Option Exercise
17,295—51,887(D)

View →

Mar 5, 2026Mar 9 8:10 PMPlacid JoverSee "Remarks"
Option Exercise
14,150—42,453(D)

View →

Mar 5, 2026Mar 9 8:09 PMBrian SavageInterim Chief Legal Officer
Option Exercise
3,580—10,740(D)

View →

Mar 5, 2026Mar 9 8:05 PMMatthew ShieldsEVP, Global Operations
Option Exercise
17,295—51,887(D)

View →

Mar 4, 2026Mar 6 9:19 PMRichard D FrancisPresident and CEO
Option Exercise
50,223—100,446(D)

View →

Mar 4, 2026Mar 6 9:19 PMRichard D FrancisPresident and CEO
Grant/Award
136,736—136,736(D)

View →

Mar 4, 2026Mar 6 9:17 PMRichard DaniellEVP, Europe Commercial
Option Exercise
53,973—40,923(D)

View →

Mar 4, 2026Mar 6 9:17 PMRichard DaniellEVP, Europe Commercial
Grant/Award
33,424—33,424(D)

View →

Mar 4, 2026Mar 6 9:16 PMPlacid JoverSee "Remarks"
Grant/Award
37,982—37,982(D)

View →